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Introduction 13
Synthetic biology has emerged as a powerful discipline for the creation of novel 14 biological systems (Endy, 2005; Pleiss, 2006) , particularly within the subfield of 15 metabolic pathway and product engineering (Keasling, 2008; Savage et al., 2008) . 16
Continuing efforts to characterize and understand natural enzymes and pathways have 17 opened the door for the building of synthetic pathways towards exciting and beneficial 18 compounds such as the anti-malarial drug precursor artemisinic acid (Ro et al., 2006) and 19 several branched-chain alcohols for use as biofuels (Atsumi et al., 2007) . The need for 20 synthetic metabolic routes is a consequence of the fact that the array of compounds of 21 interest for biosynthesis vastly outnumbers the availability of characterized pathways and 22 enzymes. Several key building blocks can be made biologically (Patel et al., 2006) ; 23 however, a recent report from the U.S. Department of Energy highlighted twelve 24 biomass-derived chemical targets, only half of which have known biochemical routes 25 (Werpy and Petersen, 2004) . 26
27
With the lack of characterized natural pathways to synthesize many high-value 28 compounds, we must learn to forge our own metabolic routes towards these molecular 29 6 properties and a relative position that affect the subsequent fold and function of the 82 resultant protein (Przytycka et al., 2002) . Building on the successes of a putative protein 83 grammar (Przytycka et al., 2002; Naoki and Hiroshi, 1997) , Loose et al. (2006) recently 84 demonstrated its use in the design of new antimicrobial peptides. Using the TEIRESIAS 85 algorithm (Rigoutsos and Floratos, 1998 ), a library with homology to known sequences 86 restricted to below 60% was generated with approximately 50% of designs showing some 87 antimicrobial activity. An alternative approach to modeling protein sequence/function 88 relationships involves the use of folded protein scaffolds and quantum transition state 89 models. Through detailed crystal structures and transition state models, Hederos et al. 90 (2004) noted that the active site of a glutathione transferase was of the appropriate size 91 and structure to stabilize the transition state complex of the hydrolytic degradation of a 92 thioester. By introducing a histidine residue within the active site they were able to 93 impart significant thioesterase activity. Finally, physics based free energy approaches 94 have been developed to predict protein structure/function relationships in the context of 95 antibody binding strength. While total free energy models were not a good predictor, 96 Lippow et al. (2007) found that the electrostatic interaction contributions to total energy 97 were well correlated with antibody binding affinity. Using this relationship, they were 98 able to generate an improved lysozyme antibody design which demonstrated a 140-fold 99 increase in binding.
While neither of these examples fully describe protein 100 structure/function relationships, each does offer a unique insight into the problem. 101 Namely, they drastically reduced the sequence space of potential modifications to a 102 manageable subset with a high probability of success. In this manner, such empirical 103 models serve as an important tool in the design and improvement of enzymes. 7 105 Using a quantum transition state framework, great strides have been made in the in silico 106 development of enzyme activities (Jiang et al., 2008; Rothlisberger et al., 2008; Kaplan 107 and Degrado, 2004) . At the heart of these efforts is a strong understanding of the desired 108 catalytic mechanism and its associated transition states and reaction intermediates. Once 109 compiled, this information can be used to generate an active site of the appropriate 110 dimensions with critical residues incorporated into appropriate locations for catalysis. At 111 this point, the designer has two options: try to identify a suitable folded scaffold that can 112 accommodate the active site with minimal mutations or generate a protein backbone with 113 correctly folded active site de novo. Each method has its inherent advantages and 114 challenges. While finding a host scaffold would appear to be the simpler of the two, it 115 requires extensive searches of protein structure libraries with tools such as RosettaMatch 116 (Zanghellini et al., 2006) . Nonetheless, this approach has had some success with the 117 catalysis of unnatural reactions such as the retro-aldol catalysis of 4-hydroxy-4-(6-118 methoxy-2-naphthyl)-2-butanone (Jiang et al., 2008) Typically multiple, and indeed in some cases, several thousand, metabolic routes can be 318
proposed for a given compound. How does one distinguish logical, feasible pathways 319 from frivolous, improbable ones? What metrics can be applied to judge one 320 computationally-generated pathway as superior (i.e. more likely to be functionally 321 constructed) to another? One way of narrowing the choice of pathways is to apply 322 natural precedent to filter out unlikely pathway steps. In this strategy, a large set of 323 experimentally validated enzyme-catalyzed reactions are examined for patterns of 324 structural change and a series of rules are developed to give preference to reaction steps 325 containing structural changes that follow these rules. This methodology is implemented 326 in the UM-BBD to avoid the "combinatorial explosion" that results when considering all 327 the possible pathways that any given compound can take (Fenner et al., 2008) . Another 328 ranking strategy is to calculate the thermodynamic favorability of the steps and to 329 penalize pathways involving steps which are energetically unfavorable. This approach is 330 taken by the BNICE framework This multifunctional enzyme has many domains designed to catalyze the various 392 reductions and condensations necessary for fatty acid synthesis (Meurer et al., 1991) . By 393 specifically inactivating the ketoacyl-reductase domain of this fatty acid synthase, the 394 enzyme could no longer use NADPH to reduce its acetyl-CoA condensation products, 395 causing them to circularize into triacetic acid lactone rather than forming linear fatty 396 acids. Finally, natural products can be synthesized by arranging whole or partial 397 pathways to form a mixed, synthetic metabolic route. For example, the theoretical yield 398 of L-glutamate was improved from 1 mol glutamate per mol glucose to 1.2 mol per mol 399 by augmenting the native Corynebacterium glutamicum pentose phosphate pathway with 400 20 a phosphoketolase from Bifidobacterium lactis (Chinen et al., 2007) . This strategy 401 allowed for the production of acetyl-CoA without the loss of carbon caused by pyruvate 402 decarboxylation to acetyl-CoA and resulted in increased glutamate titers and 403 productivity. 404
405
One of the most promising (and challenging) strategies for building synthetic pathways is 406 de novo pathway construction: the creation of pathways using disparate enzymes to form 407 entirely unnatural metabolic routes towards valuable compounds. This method of 408 pathway building does not rely upon natural precedent, but rather allows one to build 409 entirely new metabolite conduits from individual enzymatic pieces. As a result, this 410 approach allows for the biosynthesis of the widest array of compounds. On the other 411 hand, this strategy is the most difficult to realize given that for a completely unnatural 412 pathway, there may not be a complete set of appropriate known enzymes in nature to 413 build it. De novo pathway construction illustrates the need for a more complete set of 414 enzymatic tools for use in building synthetic pathways, and frequently this strategy is 415 coupled with enzyme engineering or the exploitation of enzymatic promiscuity to 416 compensate for the absence of a natural enzyme to execute a desired conversion step. The design and assembly of unnatural metabolic pathways represents a young and 450 exciting field with the potential to supplement, expand upon, or even replace current 451 industrial processes for the production of fine and commodity chemicals. Synthetic 452 pathway engineering integrates many components and consequently is highly 453 interdisciplinary ( Figure 1) . Key issues that need to be overcome in pathway design are 454
(1) establishing a standard for generalized enzyme-catalyzed reactions, (2) capturing 455 enzyme substrate preferences in these generalized reactions, and (3) determining the 456 pathway metrics that correlate with successful pathway construction. Overcoming the 457 first two challenges will allow for the creation of the next generation of pathway design 458 tools that better account for enzyme behavior, while conquering the last challenge will 459 afford us the ability to rank and choose metabolic pathways and refine the results from 460 design tools. For experimentally implementing unnatural pathways, the central challenge 461
is the limited number of characterized enzymes for the construction of new pathways. In 462 particular, there is great demand for both promiscuous natural enzymes and engineered 463 enzymes to perform specific desired reactions. 
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